UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

The American journal of cardiology, 2002-11, Vol.90 (10), p.1084-1091

2002

Volltextzugriff (PDF)

Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals

The American journal of cardiology, 2004-06, Vol.93 (12), p.1481-1486

2004

Volltextzugriff (PDF)

Historical Control Data Borrowing for Noninferiority Assessment

Statistics in biopharmaceutical research, 2022-10, Vol.14 (4), p.463-472

2022

Volltextzugriff (PDF)

Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-07, Vol.22 (4), p.633-649

2023

Volltextzugriff (PDF)

Efficacy and safety of lixisenatide in elderly ( ≥65 years old) and very elderly ( ≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme

Diabetes/metabolism research and reviews, 2015-02, Vol.31 (2), p.204-211

2015

Volltextzugriff (PDF)

The Association Between Chronic Illness and Functional Change Among Participants in a Comprehensive Geriatric Assessment Program

Journal of the American Geriatrics Society (JAGS), 1998-06, Vol.46 (6), p.677-682

1998

Volltextzugriff (PDF)

Considerations for pediatric trial designs and analyses

Journal of biopharmaceutical statistics, 2018-05, Vol.28 (3), p.413-436

2018

Volltextzugriff (PDF)

On Bayesian calculations for mixture likelihoods and priors

Statistics in medicine, 1999-06, Vol.18 (12), p.1555-1570

1999

Volltextzugriff (PDF)

Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia

Pediatrics (Evanston), 2005-09, Vol.116 (3), p.682-688

2005

Volltextzugriff (PDF)

Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2015-05, Vol.14 (3), p.161-171

2015

Volltextzugriff (PDF)

Bayesian marginal influence assessment

Journal of statistical planning and inference, 1998-08, Vol.71 (1), p.163-177

1998

Volltextzugriff (PDF)

Considerations for Design and Data Analysis of Noninferiority/Superiority Cardiovascular Trials

Journal of biopharmaceutical statistics, 2013-01, Vol.23 (1), p.239-260

2013

Volltextzugriff (PDF)

Adaptive design and timeline prediction for cardiovascular event trials for a non-inferiority/superiority claim

Communication in statistics. Case studies and data analysis, 2015-04, Vol.1 (2), p.71-84

2015

Volltextzugriff (PDF)

Long-term safety and tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment : A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study

Clinical therapeutics, 2005-02, Vol.27 (2), p.174-184

2005

Volltextzugriff (PDF)

Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study

Clinical therapeutics, 2005-02, Vol.27 (2), p.174-184

2005

Volltextzugriff (PDF)

Ezetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemia

Journal of the American College of Cardiology, 2002-03, Vol.39, p.245-245

2002

Volltextzugriff (PDF)

Fitting the log-F Accelerated Failure Time Model with Incomplete Covariate Data

Biometrics, 1999-09, Vol.55 (3), p.826-833

1999

Volltextzugriff (PDF)

Bayesian Identification of Outliers in Computerized Adaptive Tests

Journal of the American Statistical Association, 1998-09, Vol.93 (443), p.910-919

1998

Volltextzugriff (PDF)

Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia

Clinical cardiology (Mahwah, N.J.), 2003-01, Vol.26 (1), p.18-24

2003

Volltextzugriff (PDF)

Bayesian analysis for the accelerated failure time model with incomplete covariate data

Cho, Meehyung

1998

Volltextzugriff (PDF)

Survival analysis with long-term survivors and partially observed covariates

Canadian journal of statistics, 2001-09, Vol.29 (3), p.421-436

2001

Volltextzugriff (PDF)

Adaptive design and timeline prediction for cardiovascular event trials for a non-inferiority/superiority claim

Communications in Statistics: Case Studies, Data Analysis and Applications, 2015, Vol.1 (2), p.71-84

2015

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals

Historical Control Data Borrowing for Noninferiority Assessment

Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint

Efficacy and safety of lixisenatide in elderly ( ≥65 years old) and very elderly ( ≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme

The Association Between Chronic Illness and Functional Change Among Participants in a Comprehensive Geriatric Assessment Program

Considerations for pediatric trial designs and analyses

On Bayesian calculations for mixture likelihoods and priors

Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia

Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process

Bayesian marginal influence assessment

Considerations for Design and Data Analysis of Noninferiority/Superiority Cardiovascular Trials

Adaptive design and timeline prediction for cardiovascular event trials for a non-inferiority/superiority claim

Long-term safety and tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment : A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study

Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study

Ezetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemia

Fitting the log-F Accelerated Failure Time Model with Incomplete Covariate Data

Bayesian Identification of Outliers in Computerized Adaptive Tests

Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia

Bayesian analysis for the accelerated failure time model with incomplete covariate data

Survival analysis with long-term survivors and partially observed covariates

Adaptive design and timeline prediction for cardiovascular event trials for a non-inferiority/superiority claim

Suchergebnisse filtern